Drug Actives from Bench into Market.
Home About Girindus Capabilities Investor Relations Contact us Sitemap
Deutsch
IR
Investor Relations
News
Analysts' Viewpoint
Corporate Calendar
IR Contacts
Financial Reports
Factsheet
Stock Quote

Girindus  Factsheet

 
ISIN: DE0005880405
SCN: 588040
Trading segment: Prime Standard
Stock exchange: Frankfurt
Financial syndicate: Lead-managed:
Sal. Oppenheim jr. & Cie KGaA
Stock exchange identifier: Gir
First quotation: May 16, 2024
Subscription price: 20 EUR
Nominal value: 1 EUR
Shareholder structure
Solvay Organics GmbH:  75%
Free-float:  25%
Capital stock after flotation: 6.50 Mio. EUR
Sales in million EUR:
2002:  27.6
2003:  31.5
2004:  23,1
Earning per share:
2002:  -0.76
2003:  -0.55
2004:  -1,29
End of the business year: 31st of December
Number of employers:
2002:  144
2003:  131
2004:  142
Board of management:
Chief Executive Officer:  Robert F. Link
Chief Financial Officer:  Klaus R. Leineweber
Legal Affairs and HR:  Dr. jur. Harald Mothes
Technical Operations, R&D;:  Dr. Hans Hiller
 
Supervisory board:
Chairman:  Dr. Eberhard Piepho
Deputy Chairman:  Dr. Karl-Heinz Köppinger
Member:  Fritz Link
Address: Girindus AG
Buchenallee 20
D-51402 Bensberg, Germany
Internet: www.girindus.com
Contact: Peter J. Bergsteiner
Telefon: +49(0)2204 – 926 900
Telefax: +49(0)2204 – 926 990
eMail: pbergsteiner@girindus.com


2002 EUR'000 2003 EUR'000 2004 EUR'000
Net Sales 27.600 31.500 23.100
EBITDA -1.000 0 -4.900
EBIT -4.100 -2.800 -7.300
Net loss/ Net income -4.700 -3.200 -7.700
Stockholders' equity as of Dec. 31 34.300 30.000 23.800
Fixed assets as of Dec. 31 23.200 19.700 18.500
Current assets as of Dec. 31 27.900 26.000 16.800
Earnings per share -0.76 EUR -0.55 EUR -1,29
Balance sheet total 53.500 47.800 37.600
Equity to assets 64.0% 63.0% 63.0%

back to top